Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
NRC HEALTH
Report date December 31, 2024 · Filed April 10, 2025
Section 16 reporting ended · disclosed 2025-04-10. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Amandla, LLC | 0 |
Reported balance
After 2024-12-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2024-12-31 · Gift · Disposed 4,755,317 · Balance 0 F1: On December 31, 2024, Amandla MK Trust was decanted to Common Property Trust. As a result, Common Property Trust became the sole owner of Amandla, LLC. The 4,755,317 shares held by Amandla, LLC as of December 31, 2024, reflects that 923,955 shares were transferred from Amandla II, LLC (then an indirect wholly owned subsidiary of Amandla MK Trust) to Amandla, LLC on April 5, 2024. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 31, 2024, Amandla MK Trust was decanted to Common Property Trust. As a result, Common Property Trust became the sole owner of Amandla, LLC. The 4,755,317 shares held by Amandla, LLC as of December 31, 2024, reflects that 923,955 shares were transferred from Amandla II, LLC (then an indirect wholly owned subsidiary of Amandla MK Trust) to Amandla, LLC on April 5, 2024.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 28, 2022 Filed Nov 1, 2022 21:29 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 14,872 | $40.98 | $609,502.15 |
DisclosureSEC source: 0001567619-22-019031 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,465,732 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.455, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2) and (3) of this Form 4. Read SEC document |
| October 27, 2022 Filed Oct 27, 2022 21:50 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 23,038 | $40.55 | $934,190.90 |
DisclosureSEC source: 0001567619-22-018863 · doc1.xml · nonDerivative · entry 3 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,480,604 F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.865, inclusive. Read SEC document |
| October 26, 2022 Filed Oct 27, 2022 21:50 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,498 | $40.61 | $385,683.39 |
DisclosureSEC source: 0001567619-22-018863 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,503,642 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.84, inclusive. Read SEC document |
| October 25, 2022 Filed Oct 27, 2022 21:50 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,188 | $40.61 | $170,080.54 |
DisclosureSEC source: 0001567619-22-018863 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,513,140 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.835, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2) and (3) of this Form 4. Read SEC document |
| October 24, 2022 Filed Oct 24, 2022 21:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,874 | $40.61 | $400,947.59 |
DisclosureSEC source: 0001567619-22-018729 · doc1.xml · nonDerivative · entry 3 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,517,328 F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.105, inclusive. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 21:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 8,755 | $40.59 | $355,384.71 |
DisclosureSEC source: 0001567619-22-018729 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,527,202 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.785, inclusive. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 21:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,815 | $40.55 | $235,794.76 |
DisclosureSEC source: 0001567619-22-018729 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,535,957 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.79, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2) and (3) of this Form 4. Read SEC document |
| October 19, 2022 Filed Oct 19, 2022 21:26 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,089 | $40.85 | $371,266.56 |
DisclosureSEC source: 0001567619-22-018621 · doc1.xml · nonDerivative · entry 4 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,541,772 F4 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.1675, inclusive. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 21:26 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 743 | $41.62 | $30,924.48 |
DisclosureSEC source: 0001567619-22-018621 · doc1.xml · nonDerivative · entry 3 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,550,861 F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $41.50 to $41.65, inclusive. Read SEC document |
| October 18, 2022 Filed Oct 19, 2022 21:26 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 13,332 | $41.01 | $546,727.99 |
DisclosureSEC source: 0001567619-22-018621 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,551,604 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.49, inclusive. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 21:26 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 9,720 | $40.63 | $394,915.82 |
DisclosureSEC source: 0001567619-22-018621 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,564,936 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.88, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2), (3) and (4) of this Form 4. Read SEC document |
| October 14, 2022 Filed Oct 14, 2022 21:08 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 6,039 | $40.65 | $245,506.49 |
DisclosureSEC source: 0001567619-22-018518 · doc1.xml · nonDerivative · entry 3 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,574,656 F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.12, inclusive. Read SEC document |
| October 13, 2022 Filed Oct 14, 2022 21:08 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 36,137 | $40.85 | $1,476,207.29 |
DisclosureSEC source: 0001567619-22-018518 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,580,695 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.26, inclusive. Read SEC document |
| October 12, 2022 Filed Oct 14, 2022 21:08 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,600 | $40.51 | $64,812.48 |
DisclosureSEC source: 0001567619-22-018518 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,616,832 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.575, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2) and (3) of this Form 4. Read SEC document |
| October 04, 2022 Filed Oct 4, 2022 21:39 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 11,294 | $40.74 | $460,084.81 |
DisclosureSEC source: 0001567619-22-018207 · doc1.xml · nonDerivative · entry 3 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,618,432 F3 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $41.055, inclusive. Read SEC document |
| October 03, 2022 Filed Oct 4, 2022 21:39 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 31,118 | $40.53 | $1,261,346.35 |
DisclosureSEC source: 0001567619-22-018207 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,629,726 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.50 to $40.645, inclusive. Read SEC document |
| September 30, 2022 Filed Oct 4, 2022 21:39 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 795 | $40.59 | $32,271.04 |
DisclosureSEC source: 0001567619-22-018207 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,660,844 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.575 to $40.595, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1), (2) and (3) of this Form 4. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 18:44 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 100,000 | $38.59 | $3,858,900.00 |
DisclosureSEC source: 0001567619-22-017526 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,661,639 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $38.53 to $38.63, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in this footnote. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 20:18 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 246,378 | $36.00 | $8,869,608.00 |
DisclosureSEC source: 0001567619-22-012770 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 4,761,639 F1 · balance_after: Reflects the transfer of shares between Amandla II LLC and Amandla LLC. Amandla MK Trust owns 100% of Amandla II LLC and Amandla II LLC owns 100% of Amandla LLC. Accordingly, such transfer constitutes a mere change in form of indirect beneficial ownership and is not separately reported. Read SEC document |
| April 21, 2022 Filed Apr 25, 2022 21:17 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 100 | $39.87 | $3,987.00 |
DisclosureSEC source: 0001567619-22-008916 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,931,972 Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:48 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,200 | $39.92 | $87,813.44 |
DisclosureSEC source: 0001567619-22-008813 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,932,072 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $39.76 to $40.41, inclusive. Read SEC document |
| April 19, 2022 Filed Apr 21, 2022 20:48 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,322 | $39.90 | $52,743.31 |
DisclosureSEC source: 0001567619-22-008813 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,934,272 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $39.805 to $40.035, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| April 08, 2022 Filed Apr 11, 2022 20:52 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 600 | $40.03 | $24,015.00 |
DisclosureSEC source: 0001567619-22-008357 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,935,594 Read SEC document |
| April 07, 2022 Filed Apr 11, 2022 20:52 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,800 | $40.48 | $72,865.98 |
DisclosureSEC source: 0001567619-22-008357 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,936,194 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.095 to $40.695, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 06, 2022 Filed Apr 7, 2022 20:22 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 8,137 | $40.71 | $331,252.39 |
DisclosureSEC source: 0001567619-22-008247 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,937,994 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.155 to $40.995, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 05, 2022 Filed Apr 6, 2022 20:08 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,627 | $40.39 | $227,286.35 |
DisclosureSEC source: 0001567619-22-008189 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,946,131 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $40.28 to $40.595, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 20:08 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 2,500 | $40.15 | $100,375.00 |
DisclosureSEC source: 0001567619-22-008189 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,951,758 Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:02 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,886 | $42.76 | $208,907.28 |
DisclosureSEC source: 0001567619-21-022617 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,954,258 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $42.50 to $42.90, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:02 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 164 | $42.50 | $6,970.00 |
DisclosureSEC source: 0001567619-21-022617 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,959,144 Read SEC document |
| December 17, 2021 Filed Dec 21, 2021 21:17 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,845 | $42.57 | $248,827.50 |
DisclosureSEC source: 0001567619-21-022395 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,959,308 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $42.50 to $42.695, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 13, 2021 Filed Dec 14, 2021 21:04 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 18,386 | $42.66 | $784,354.11 |
DisclosureSEC source: 0001567619-21-022016 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,965,153 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $42.51 to $42.90, inclusive. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 21:04 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 45,183 | $42.60 | $1,924,660.25 |
DisclosureSEC source: 0001567619-21-022016 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 5,983,539 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $42.50 to $43.27, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| December 07, 2021 Filed Dec 9, 2021 21:05 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 8,640 | $43.33 | $374,406.62 |
DisclosureSEC source: 0001567619-21-021830 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,028,722 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $43.11 to $43.685, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 21:19 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 11,343 | $43.01 | $487,806.85 |
DisclosureSEC source: 0001567619-21-021706 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,037,362 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $42.75 to $43.385, inclusive. Read SEC document |
| December 03, 2021 Filed Dec 7, 2021 21:19 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 118,631 | $42.44 | $5,035,114.85 |
DisclosureSEC source: 0001567619-21-021706 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,048,705 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $42.00 to $42.78, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 21:17 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 100 | $49.00 | $4,900.00 |
DisclosureSEC source: 0001567619-21-019568 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,167,336 Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:34 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 50,000 | $50.06 | $2,502,770.00 |
DisclosureSEC source: 0001567619-21-019406 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,167,436 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $50.025 to $50.275, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 18:06 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 11,997 | $54.16 | $649,809.11 |
DisclosureSEC source: 0001567619-21-016719 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,217,436 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $54.00 to $54.45, inclusive. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 18:06 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 4,157 | $54.03 | $224,610.61 |
DisclosureSEC source: 0001567619-21-016719 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,229,433 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $54.00 to $54.10, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| August 31, 2021 Filed Sep 1, 2021 20:15 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 3,029 | $54.00 | $163,567.21 |
DisclosureSEC source: 0001567619-21-016552 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,233,590 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $54.00 to $54.01, inclusive. Read SEC document |
| August 30, 2021 Filed Sep 1, 2021 20:15 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 817 | $54.15 | $44,236.71 |
DisclosureSEC source: 0001567619-21-016552 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,236,619 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $54.00 to $54.605, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| May 25, 2021 Filed May 26, 2021 20:44 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 10,647 | $50.01 | $532,453.28 |
DisclosureSEC source: 0001567619-21-011193 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,237,436 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $50.00 to $50.14, inclusive. Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:44 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 5,638 | $49.98 | $281,796.26 |
DisclosureSEC source: 0001567619-21-011193 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,248,083 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $49.63 to $50.07, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:15 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 11,334 | $50.96 | $577,578.37 |
DisclosureSEC source: 0001567619-21-011130 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,253,721 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $50.85 to $50.965, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 04, 2021 Filed May 6, 2021 19:40 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,233 | $51.14 | $63,053.28 |
DisclosureSEC source: 0001567619-21-009206 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,265,055 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $51.10 to $51.27, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| May 03, 2021 Filed May 4, 2021 20:35 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 1,548 | $51.95 | $80,423.86 |
DisclosureSEC source: 0001567619-21-008984 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,266,288 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $51.95 to $52.065, inclusive. Read SEC document |
| April 30, 2021 Filed May 4, 2021 20:35 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 14,742 | $51.07 | $752,912.27 |
DisclosureSEC source: 0001567619-21-008984 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,267,836 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $51.00 to $51.72, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges set forth in footnotes (1) and (2) of this Form 4. Read SEC document |
| April 29, 2021 Filed Apr 30, 2021 20:03 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 30,700 | $50.38 | $1,546,666.00 |
DisclosureSEC source: 0001567619-21-008791 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,282,578 Read SEC document |
| April 28, 2021 Filed Apr 30, 2021 20:03 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 50,000 | $49.36 | $2,468,130.00 |
DisclosureSEC source: 0001567619-21-008791 · doc1.xml · nonDerivative · entry 1 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,313,278 F1 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $49.02 to $49.365, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the ranges. Read SEC document |
| March 03, 2021 Filed Mar 4, 2021 22:16 UTC | NRC HEALTH NRC · Entity 5534 | SaleCommon Stock | 740 | $54.06 | $40,005.73 |
DisclosureSEC source: 0001567619-21-005664 · doc1.xml · nonDerivative · entry 2 Amandla MK Trust · CIK 0001729470 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Amandla LLC Disclosed balance after: 6,363,278 F2 · price: The price in Column 4 is a weighted average price. The prices actually ranged from $54.00 to $54.26, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.